Experienced in Lung Metastases

Xiaoyan M. Xie

No. 28 Fuxing Rd, 
Beijing, CN 
Experienced in Lung Metastases
No. 28 Fuxing Rd, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Xiaoyan Xie practices in Beijing, China. Xie is rated as an Experienced expert by MediFind in the treatment of Lung Metastases. Their top areas of expertise are Liver Cancer, Biliary Atresia, Hepatic Hemangioma, Cardiac Ablation, and Hepatectomy.

Their clinical research consists of co-authoring 227 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Lung Metastases.

Locations

No. 28 Fuxing Rd, Beijing, 100853, China
Other Locations
58 Zhongshan Road 2nd, Guangzhou, 510080, China
No. 18 Daoshan Road, Fuzhou, 350001, China
No. 27 Taiping Road, Haidian, 100850, China
58 Zhong Shan Road 2, Guangzhou, 510080, China
No. 58 Zhongshan Second Road, Guangzhou, 510080, China
No. 132 East Waihuan Road, Guangzhou, 510006, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Single-Arm, Prospective, Multicenter Study to Evaluate the Safety and Effectiveness of the NeuWave Certus Microwave Ablation System in Chinese Patients With Hepatocellular Carcinoma
A Single-Arm, Prospective, Multicenter Study to Evaluate the Safety and Effectiveness of the NeuWave Certus Microwave Ablation System in Chinese Patients With Hepatocellular Carcinoma
Enrollment Status: Completed
Publish Date: April 25, 2025
Intervention Type: Device
Study Phase: Not Applicable

227 Total Publications

Do Prognostic Differences Exist Among High-Risk RET Mutations? A Comparison of Outcomes Between the RET C634R and Other C634 Mutations in Hereditary Medullary Thyroid Carcinoma.
Do Prognostic Differences Exist Among High-Risk RET Mutations? A Comparison of Outcomes Between the RET C634R and Other C634 Mutations in Hereditary Medullary Thyroid Carcinoma.
Journal: Thyroid : official journal of the American Thyroid Association
Published: September 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Xie's expertise for a condition
ConditionClose
    View All 40 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile